Original Research

Published on 10 Jan 2025

Retinal biomarkers for the risk of Alzheimer’s disease and frontotemporal dementia

in Alzheimer's Disease and Related Dementias

Ruihan Wang
Jiajie Cai
Yuzhu Gao
Yingying Tang
Hui Gao
Linyuan Qin
Hanlin Cai
Feng Yang
Yimeng Ren
Caimei Luo

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1513302

297 views

Original Research

Accepted on 09 Jan 2025

Hypertension moderates the relationship between plasma beta-amyloid and cognitive impairment: A cross-sectional study in Xi'an, China

in Alzheimer's Disease and Related Dementias

Ziyu Liu
Yaoli He
Simeng Cui
Liangjun Dang
Binyan Zhang
Jin Wang
Wenhui Lu
Kang Huo
Yu Jiang
Chen Chen

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1532676

Original Research

Accepted on 09 Jan 2025

Untargeted Urine Metabolomics Reveals Dynamic Metabolic Differences and Key Biomarkers Across Different Stages of Alzheimer's Disease

in Alzheimer's Disease and Related Dementias

Xiaoya Feng
Shenglan Zhao

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1530046

Original Research

Accepted on 08 Jan 2025

Lingguizhugan Decoction enhances autophagy of Alzheimer's disease via regulating the mTOR/ p70s6K pathway in vivo and in vitro

in Alzheimer's Disease and Related Dementias

Chunxiang Zhou
Xiaojing Chen
Qingrong Tian
Min Gao
Xibin Zhou

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1478199

Original Research

Accepted on 08 Jan 2025

Diagnostic potential of urinary CX3CL1 for amnestic mild cognitive impairment and Alzheimer's disease

in Alzheimer's Disease and Related Dementias

Yali Xu
Jie Zhang
Ying-Ying Shen
Wei-Wei Li
Bin Li
Hai-Ping Cheng
Gui-Hua Zeng

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1501762

Retraction

Accepted on 08 Jan 2025

Retraction: Associations of Vitamin D Receptor Polymorphisms with Risk of Alzheimer's Disease, Parkinson's disease and Mild Cognitive Impairment: A Systematic Review and Meta-analysis

in Alzheimer's Disease and Related Dementias

Frontiers Editorial Office

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1557340

Original Research

Published on 08 Jan 2025

Decreased prefrontal activation during verbal fluency task after repetitive transcranial magnetic stimulation treatment for depression in Alzheimer’s disease: a functional near-infrared spectroscopy study

in Alzheimer's Disease and Related Dementias

Yuanzhi Zhao
Conglong Qiu
Ping Lin
Mei Yang
Ling Huang
Zheng Zhao
Xiangping Wu
Dongsheng Zhou

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1460853

371 views

Review

Published on 07 Jan 2025

Potential biomarkers for cerebral small vessel disease with cognitive impairment: a systematic review and meta-analysis

in Alzheimer's Disease and Related Dementias

Libin Liao
Weiquan Huang
Rongchao Ma
Xuan He
Moxi Su
Dujuan Sha

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1475571

257 views

Original Research

Published on 07 Jan 2025

Age-dependent phenotypes of cognitive impairment as sequelae of SARS-CoV-2 infection

in Alzheimer's Disease and Related Dementias

Gabriela Gonzalez Aleman
George D. Vavougios
Carmela Tartaglia
Nalakath A. Uvais
Alla Guekht
Akram A. Hosseini
Vincenzina Lo Re
Catterina Ferreccio
Giovanni D'Avossa
Hernan P. Zamponi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1432357

533 views

Original Research

Published on 07 Jan 2025

Therapeutic potential of hydrogen-rich water in zebrafish model of Alzheimer’s disease: targeting oxidative stress, inflammation, and the gut-brain axis

in Alzheimer's Disease and Related Dementias

Jiaxuan He
Peiye Xu
Ting Xu
Haiyang Yu
Lei Wang
Rongbing Chen
Kun Zhang
Yueliang Yao
Yanyan Xie
Qinsi Yang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1515092

473 views

Review

Accepted on 06 Jan 2025

Imaging markers of cerebral small vessel disease are associated with Alzheimer's disease: A systematic review and meta-analysis

in Alzheimer's Disease and Related Dementias

Qi Wu
Ju Peng Zhang
Lei Peng
Xiqi Zhu
Changhui Huang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2025.1498636

Original Research

Published on 06 Jan 2025

Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study

in Alzheimer's Disease and Related Dementias

Chengyong Liu
Chi Wang
Jing Jiang
Yuyang Bo
Lixiu Nan
Ying Zhang
Kongxi Zhu
Xiaoqiu Wang
Xinxin Feng
Xiaoyang Lian

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1436171

701 views

Original Research

Published on 06 Jan 2025

An EEG-based framework for automated discrimination of conversion to Alzheimer’s disease in patients with amnestic mild cognitive impairment: an 18-month longitudinal study

in Alzheimer's Disease and Related Dementias

Yingfeng Ge
Jianan Yin
Caie Chen
Shuo Yang
Yuduan Han
Chonglong Ding
Jiaming Zheng
Yifan Zheng
Jinxin Zhang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1470836

539 views

Editorial

Published on 06 Jan 2025

Editorial: Animal models of Alzheimer's disease and other dementias: past, present, and future

in Alzheimer's Disease and Related Dementias

Ines Moreno-Gonzalez
Jesus Garcia-Martin
Roberta Marongiu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1539837

506 views

Review

Published on 06 Jan 2025

Dynamic retinal vessel analysis: flickering a light into the brain

in Alzheimer's Disease and Related Dementias

Anna Peterfi
Ana Clara da C. Pinaffi-Langley
Zsofia Szarvas
Mihaly Muranyi
Zalan Kaposzta
Cheryl Adams
Camila Bonin Pinto
Peter Mukli
Konstantin Kotliar
Andriy Yabluchanskiy

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1517368

422 views

Original Research

Published on 03 Jan 2025

Pharmacological enhancement of slow-wave activity at an early disease stage improves cognition and reduces amyloid pathology in a mouse model of Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Sedef Kollarik
Dorita Bimbiryte
Aakriti Sethi
Inês Dias
Carlos G. Moreira
Daniela Noain

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1519225

335 views

Navigation group

Articles

Retinal biomarkers for the risk of Alzheimer’s disease and frontotemporal dementia

Hypertension moderates the relationship between plasma beta-amyloid and cognitive impairment: A cross-sectional study in Xi'an, China

Untargeted Urine Metabolomics Reveals Dynamic Metabolic Differences and Key Biomarkers Across Different Stages of Alzheimer's Disease

Lingguizhugan Decoction enhances autophagy of Alzheimer's disease via regulating the mTOR/ p70s6K pathway in vivo and in vitro

Diagnostic potential of urinary CX3CL1 for amnestic mild cognitive impairment and Alzheimer's disease

Retraction: Associations of Vitamin D Receptor Polymorphisms with Risk of Alzheimer's Disease, Parkinson's disease and Mild Cognitive Impairment: A Systematic Review and Meta-analysis

Decreased prefrontal activation during verbal fluency task after repetitive transcranial magnetic stimulation treatment for depression in Alzheimer’s disease: a functional near-infrared spectroscopy study

Potential biomarkers for cerebral small vessel disease with cognitive impairment: a systematic review and meta-analysis

Age-dependent phenotypes of cognitive impairment as sequelae of SARS-CoV-2 infection

Therapeutic potential of hydrogen-rich water in zebrafish model of Alzheimer’s disease: targeting oxidative stress, inflammation, and the gut-brain axis

Imaging markers of cerebral small vessel disease are associated with Alzheimer's disease: A systematic review and meta-analysis

Role of metabolic characteristics in the co-occurrence of insomnia, Alzheimer’s disease, and Parkinson’s disease: a Mendelian randomization study

An EEG-based framework for automated discrimination of conversion to Alzheimer’s disease in patients with amnestic mild cognitive impairment: an 18-month longitudinal study

Editorial: Animal models of Alzheimer's disease and other dementias: past, present, and future

Dynamic retinal vessel analysis: flickering a light into the brain

Pharmacological enhancement of slow-wave activity at an early disease stage improves cognition and reduces amyloid pathology in a mouse model of Alzheimer’s disease